Kadcyla 100mg & 160mg powder for concentrate for solution for infusion

Company:
Roche Registration GmbH
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Trastuzumab Emtansine
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/13/885/001

100 milligram(s)

L01FD03,L01FD

Powder for concentrate for Solution for infusion

EU/1/13/885/002

160 milligram(s)

L01FD03,L01FD

Powder for concentrate for Solution for infusion